Call for papers: Cell and molecular therapy for cardiovascular disorders
Published in Healthcare & Nursing and General & Internal Medicine
BMC Cardiovascular Disorders is calling for submissions to our Collection on cell and molecular therapy for cardiovascular diseases. Scientists from around the globe are investigating/leveraging cell and molecular-based strategies to protect, regenerate, replace, and restore the function of cardiac and vascular tissue. Advances in basic and clinical research have yielded encouraging findings highlighting the promise of such strategies to treat a range of CVDs. However, gaps in our knowledge remain and further research is required to translate findings from basic research into the clinic.
In support of SDG 3: Good Health & Wellbeing, BMC Cardiovascular Disorders calls for papers exploring the potential of stem cells, gene editing, tissue engineering, disease modeling, and organoids to improve our understanding of cardiovascular diseases and open new avenues for therapeutic intervention.
Meet the Guest Editors
Sherin Saheera: University of Massachusetts Chan Medical School, USDr Sherin Saheera completed her PhD in India in 2017 and went to the US to pursue her postdoctoral studies. After a year of training at the University of Alabama at Birmingham, she is currently working as a Postdoctoral Associate at the University of Massachusetts, Chan Medical School, where she has been since January 2019. She has over 18 publications in peer reviewed high impact journals and has been serving as an editorial board member and reviewer for reputed journals. She has also presented papers in several national and international conferences.
Huiliang Zhang: University of Arkansas for Medical Sciences, US
Dr Zhang’s research focuses on cardiac dysfunction in the aging heart with an emphasis on the pathogenic role of elevated proton leak from mitochondria. He explores the strategies for restoring mitochondrial function and stem cell therapies to reverse cardiac dysfunction in preclinical models of aging. Dr. Zhang is the principal investigator of the NIH R35 grant and the American Heart Association (AHA) Career Development Award. Dr. Zhang served in NIH and AHA study sections. He has nearly 40 original publications and has won several national trainee and junior faculty awards.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Cell and molecular therapy for cardiovascular disorders" from the dropdown menu.Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 21 June 2024
Follow the Topic
-
BMC Cardiovascular Disorders
This journal is an open access, peer-reviewed journal that considers articles on the characterization, prevention, diagnosis and treatment of disorders of the heart and circulatory system.
Related Collections
With collections, you can get published faster and increase your visibility.
Cardiac and vascular tissue engineering and regeneration
BMC Cardiovascular Disorders calls for submissions to a new article Collection on Cardiac and vascular tissue engineering and regeneration. Across this multidisciplinary field, researchers are helping to develop strategies to repair and regenerate cardiovascular tissue. There has been much progress in our understanding of stem cell biology and biomaterials, leading to groups testing the regenerative potential of stem cell derived cardiovascular cell types for cardiac and vascular tissue repair via direct injection or in the form of in vitro engineered tissues.
In support of SDG 3: Good Health & Well-being, this Collection seeks contributions that address a spectrum of topics, including but not limited to:
• How do you ensure transplanted cells/ engineered tissue establish functional connections with host tissue?
• How do you make cells properly mature outside the body for therapeutic purposes?
• How do you direct and deliver stem cells/ engineered tissue to sites where they are needed?
• How do we prevent the loss of transplanted cells/ engineered tissue after delivery?
• What physiological, mechanical and biochemical cues must we consider when developing therapeutic interventions?
• How can developmental biology and angiogenesis knowledge be applied in regenerative medicine for cardiovascular disorders?
Publishing Model: Open Access
Deadline: Jun 30, 2025
Women and cardiovascular disease: addressing the gender gap
BMC Cardiovascular Disorders is calling for submissions to our Collection on Women and cardiovascular disease: Addressing the gender gap. Cardiovascular disease (CVD) is the leading cause of death among women worldwide, yet women remain underrepresented in cardiovascular research. Studies have shown that women experience worse outcomes following heart attacks and are more likely to be misdiagnosed or undertreated due to differences in disease presentation and a lack of sex-specific research.
To address this gap, BMC Cardiovascular Disorders is seeking submissions for a special collection focused on women and cardiovascular disease. We invite research exploring women's challenges in CVD diagnosis, treatment, and prevention. Topics of interest include, but are not limited to, sex differences in CVD risk factors, the molecular mechanisms underlying CVD, clinical presentation, and treatment outcomes, as well as barriers to women's participation in clinical trials.
This collection also welcomes research on innovative strategies to improve cardiovascular care for women, such as public health campaigns, policy changes, and healthcare professional education. We encourage submissions highlighting interdisciplinary approaches, novel technologies, and interventions aimed at reducing the global burden of CVD in women.
This Collection is in support of SDG 3: Good Health & Well-Being and SDG 10: Reduced Inequalities.
Publishing Model: Open Access
Deadline: Aug 19, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in